Loading comparison data...
Compare ALBUTEROL (Albuterol) and Salbutamol (Ventolin (UK)) — clinical data, side effects, and patient experiences.
Albuterol, ProAir, Ventolin · Beta-2 Agonist Bronchodilator
How it works
Other agent
Approved for
Ventolin (UK), Salamol, Airomir · Beta-2 Agonist Bronchodilator
How it works
Short-acting beta-2 adrenergic agonist that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm. Known as albuterol in the US.
Approved for
Estimated frequency (%) based on clinical trial data
No data
No specific warnings
No head-to-head clinical studies found for ALBUTEROL vs Salbutamol.
Both ALBUTEROL and Salbutamol belong to the Beta-2 Agonist Bronchodilator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ALBUTEROL is administered via Oral, whereas Salbutamol uses Topical. Route of administration can affect onset of action and patient adherence.
ALBUTEROL carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.